» Articles » PMID: 34335608

The Impact of Programmed Cell Death on the Formation of Tertiary Lymphoid Structures

Overview
Journal Front Immunol
Date 2021 Aug 2
PMID 34335608
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Tertiary lymphoid structures are clusters of lymphoid tissue that develop post-natally at sites of chronic inflammation. They have been described in association with infection, autoimmune disorders, cancer, and allograft rejection. In their mature stage, TLS function as ectopic germinal centers, favoring the local production of autoantibodies and cytokines. TLS formation tends to parallel the severity of tissue injury and they are usually indicative of locally active immune responses. The presence of TLS in patients with solid tumors is usually associated with a better prognosis whereas their presence predicts increased maladaptive immunologic activity in patients with autoimmune disorders or allograft transplantation. Recent data highlight a correlation between active cell death and TLS formation and maturation. Our group recently identified apoptotic exosome-like vesicles, released by apoptotic cells, as novel inducers of TLS formation. Here, we review mechanisms of TLS formation and maturation with a specific focus on the emerging importance of tissue injury, programmed cell death and extracellular vesicles in TLS biogenesis.

Citing Articles

The Extra-Tumoral Vaccine Effects of Apoptotic Bodies in the Advancement of Cancer Treatment.

Wang Y, Liu C, Pang J, Li Z, Zhang J, Dong L Small. 2025; 21(9):e2410503.

PMID: 39871756 PMC: 11878267. DOI: 10.1002/smll.202410503.


Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances.

Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z Signal Transduct Target Ther. 2024; 9(1):225.

PMID: 39198425 PMC: 11358547. DOI: 10.1038/s41392-024-01947-5.


Tumor Microenvironment Modulation by Cancer-Derived Extracellular Vesicles.

Ten A, Kumeiko V, Farniev V, Gao H, Shevtsov M Cells. 2024; 13(8.

PMID: 38667297 PMC: 11049026. DOI: 10.3390/cells13080682.


Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application.

Zhang Y, Xu M, Ren Y, Ba Y, Liu S, Zuo A Mol Cancer. 2024; 23(1):75.

PMID: 38582847 PMC: 10998345. DOI: 10.1186/s12943-024-01980-6.


Heterogeneity of tertiary lymphoid structures in cancer.

You X, Koop K, Weigert A Front Immunol. 2023; 14:1286850.

PMID: 38111571 PMC: 10725932. DOI: 10.3389/fimmu.2023.1286850.


References
1.
Pipi E, Nayar S, Gardner D, Colafrancesco S, Smith C, Barone F . Tertiary Lymphoid Structures: Autoimmunity Goes Local. Front Immunol. 2018; 9:1952. PMC: 6143705. DOI: 10.3389/fimmu.2018.01952. View

2.
Fukami N, Ramachandran S, Saini D, Walter M, Chapman W, Patterson G . Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol. 2008; 182(1):309-18. PMC: 2802821. DOI: 10.4049/jimmunol.182.1.309. View

3.
Carlsen H, Baekkevold E, Morton H, Haraldsen G, Brandtzaeg P . Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood. 2004; 104(10):3021-7. DOI: 10.1182/blood-2004-02-0701. View

4.
Shiromizu C, Jancic C . γδ T Lymphocytes: An Effector Cell in Autoimmunity and Infection. Front Immunol. 2018; 9:2389. PMC: 6198062. DOI: 10.3389/fimmu.2018.02389. View

5.
Sato Y, Mii A, Hamazaki Y, Fujita H, Nakata H, Masuda K . Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney. JCI Insight. 2016; 1(11):e87680. PMC: 5033938. DOI: 10.1172/jci.insight.87680. View